Asthma inhaler switch in 2024 could leave some patients scrambling
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
Health care has historically been slow to adopt new technologies that involve wholesale changes to the nature of the work. Witness the slow and checkered roll-out of electronic health records and the utter failure of prior ...
Dec 1, 2023
0
1
From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses (hypofractionation) for prostate cancer, according to a brief report published online Oct. 5 in JAMA Oncology.
Oct 10, 2023
0
11
Education, income, and marital status prior to multiple sclerosis (MS) onset are associated with future symptom and disability severity, according to a study published online Sept. 26 in JAMA Network Open.
Sep 29, 2023
0
1
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.
Jul 13, 2023
0
0
Discussions about artificial intelligence have proliferated recently as more people have access to programs that can make art or answer questions.
Jul 3, 2023
0
8
Most pregnant women will have a healthy pregnancy and give birth to healthy babies. An increasing number of women, however, will either have one or more health conditions before they become pregnant which require on-going ...
Jun 26, 2023
0
1
Influential health care interests are jockeying over a potential infusion of $19.4 billion into Medi-Cal, California's Medicaid program, while also angling for a 2024 ballot initiative to permanently lock in that funding, ...
Jun 5, 2023
0
2
The cost of family health insurance plans increased just 1% this year even as inflation reached a four-decade high, with higher prices for gas, groceries, rent and other living expenses.
Oct 31, 2022
0
3
For patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port delivery system (PDS) with one refill costs more than intravitreal ranibizumab or aflibercept injections if about 11 or 10 injections, ...
Jun 23, 2022
0
2